PAMP
Polar Asset Management Partners’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-32,200
| Closed | -$1.89M | – | 688 |
|
|
2024
Q1 | $1.89M | Buy |
+32,200
| New | +$1.89M | 0.03% | 351 |
|
|
2023
Q3 | – | Sell |
-105,810
| Closed | -$9.64M | – | 850 |
|
|
2023
Q2 | $9.64M | Buy |
105,810
+6,600
| +7% | +$601K | 0.17% | 145 |
|
|
2023
Q1 | $6.54M | Buy |
99,210
+40,900
| +70% | +$2.7M | 0.1% | 238 |
|
|
2022
Q4 | $3.02M | Sell |
58,310
-324,290
| -85% | -$16.8M | 0.04% | 504 |
|
|
2022
Q3 | $26.1M | Buy |
382,600
+292,300
| +324% | +$20M | 0.31% | 38 |
|
|
2022
Q2 | $4.08M | Buy |
90,300
+42,100
| +87% | +$1.9M | 0.05% | 498 |
|
|
2022
Q1 | $2.45M | Sell |
48,200
-38,400
| -44% | -$1.95M | 0.03% | 563 |
|
|
2021
Q4 | $4.09M | Buy |
86,600
+58,600
| +209% | +$2.77M | 0.04% | 419 |
|
|
2021
Q3 | $923K | Buy |
+28,000
| New | +$923K | 0.01% | 641 |
|